F.D.A. Rushed a Drug for Preterm Births. Did It Put Speed Over Science?

The agency ’s accelerated approval program for certain drugs has come under intense scrutiny because some medicines stay on the market despite limited evidence that they work.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Drugs (Pharmaceuticals) Midodrine (Drug) Premature Babies Pregnancy and Childbirth Black People Aduhelm (Drug) Regulation and Deregulation of Industry Research Suits and Litigation (Civil) AMAG Pharmaceuticals Inc Food and Drug Adminis Source Type: news